• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 Transformer 变分自动编码器和贝叶斯优化的治疗靶标蛋白抑制剂和激活剂候选物的化学结构生成。

Generation of Chemical Structures of Inhibitor and Activator Candidates for Therapeutic Target Proteins by a Transformer-Based Variational Autoencoder and Bayesian Optimization.

机构信息

Department of Bioscience and Bioinformatics, Faculty of Computer Science and Systems Engineering, Kyushu Institute of Technology, 680-4 Kawazu, Iizuka, Fukuoka 820-8502, Japan.

Graduate School of Informatics, Nagoya University, Chikusa, Nagoya, Aichi 464-8601, Japan.

出版信息

J Chem Inf Model. 2024 Apr 8;64(7):2345-2355. doi: 10.1021/acs.jcim.3c00824. Epub 2023 Sep 28.

DOI:10.1021/acs.jcim.3c00824
PMID:37768595
Abstract

Deep generative models for molecular generation have been gaining much attention as structure generators to accelerate drug discovery. However, most previously developed methods are chemistry-centric approaches, and comprehensive biological responses in the cell have not been taken into account. In this study, we propose a novel computational method, TRIOMPHE-BOA (transcriptome-based inference and generation of molecules with desired phenotypes using the Bayesian optimization algorithm), to generate new chemical structures of inhibitor or activator candidates for therapeutic target proteins by integrating chemically and genetically perturbed transcriptome profiles. In the algorithm, the substructures of multiple molecules that were selected based on the transcriptome analysis are fused in the design of new chemical structures by exploring the latent space of a Transformer-based variational autoencoder using Bayesian optimization. Our results demonstrate the usefulness of the proposed method in terms of having high reproducibility of existing ligands for 10 therapeutic target proteins when compared with previous methods. Moreover, this method can be applied to proteins without detailed 3D structures or known ligands and is expected to become a powerful tool for more efficient hit identification.

摘要

用于分子生成的深度生成模型作为结构生成器在加速药物发现方面受到了广泛关注。然而,大多数以前开发的方法都是以化学为中心的方法,并没有考虑细胞中的全面生物学反应。在这项研究中,我们提出了一种新的计算方法,TRIOMPHE-BOA(基于转录组的推断和使用贝叶斯优化算法生成具有所需表型的分子),通过整合化学和遗传扰动转录组谱,为治疗靶蛋白生成抑制剂或激活剂候选物的新化学结构。在该算法中,基于转录组分析选择的多个分子的子结构通过使用贝叶斯优化探索基于 Transformer 的变分自动编码器的潜在空间来融合在新化学结构的设计中。我们的结果表明,与以前的方法相比,该方法在 10 种治疗靶蛋白的现有配体的高重现性方面具有实用性。此外,该方法可应用于没有详细 3D 结构或已知配体的蛋白质,有望成为更有效命中识别的有力工具。

相似文献

1
Generation of Chemical Structures of Inhibitor and Activator Candidates for Therapeutic Target Proteins by a Transformer-Based Variational Autoencoder and Bayesian Optimization.基于 Transformer 变分自动编码器和贝叶斯优化的治疗靶标蛋白抑制剂和激活剂候选物的化学结构生成。
J Chem Inf Model. 2024 Apr 8;64(7):2345-2355. doi: 10.1021/acs.jcim.3c00824. Epub 2023 Sep 28.
2
TRIOMPHE: Transcriptome-Based Inference and Generation of Molecules with Desired Phenotypes by Machine Learning.TRIOMPHE:基于转录组的机器学习推断和具有预期表型的分子生成。
J Chem Inf Model. 2021 Sep 27;61(9):4303-4320. doi: 10.1021/acs.jcim.1c00967. Epub 2021 Sep 16.
3
De novo drug design based on patient gene expression profiles via deep learning.基于深度学习的基于患者基因表达谱的从头药物设计。
Mol Inform. 2023 Aug;42(8-9):e2300064. doi: 10.1002/minf.202300064. Epub 2023 Aug 21.
4
FSM-DDTR: End-to-end feedback strategy for multi-objective De Novo drug design using transformers.FSM-DDTR:使用变压器的多目标从头药物设计的端到端反馈策略。
Comput Biol Med. 2023 Sep;164:107285. doi: 10.1016/j.compbiomed.2023.107285. Epub 2023 Jul 31.
5
RELATION: A Deep Generative Model for Structure-Based De Novo Drug Design.关系:一种基于结构的从头药物设计的深度生成模型。
J Med Chem. 2022 Jul 14;65(13):9478-9492. doi: 10.1021/acs.jmedchem.2c00732. Epub 2022 Jun 17.
6
Bayesian Optimization in the Latent Space of a Variational Autoencoder for the Generation of Selective FLT3 Inhibitors.基于变分自动编码器潜在空间的贝叶斯优化在选择性 FLT3 抑制剂生成中的应用。
J Chem Theory Comput. 2024 Jan 9;20(1):469-476. doi: 10.1021/acs.jctc.3c01224. Epub 2023 Dec 19.
7
Deep Generation Model Guided by the Docking Score for Active Molecular Design.基于对接评分的深度生成模型在活性分子设计中的应用。
J Chem Inf Model. 2023 May 22;63(10):2983-2991. doi: 10.1021/acs.jcim.3c00572. Epub 2023 May 10.
8
Sc2Mol: a scaffold-based two-step molecule generator with variational autoencoder and transformer.Sc2Mol:基于支架的两步分子生成器,结合变分自动编码器和转换器。
Bioinformatics. 2023 Jan 1;39(1). doi: 10.1093/bioinformatics/btac814.
9
cMolGPT: A Conditional Generative Pre-Trained Transformer for Target-Specific De Novo Molecular Generation.cMolGPT:一种用于靶向特定从头分子生成的条件生成式预训练转换器。
Molecules. 2023 May 30;28(11):4430. doi: 10.3390/molecules28114430.
10
Predicting inhibitory and activatory drug targets by chemically and genetically perturbed transcriptome signatures.通过化学和遗传扰动转录组特征预测抑制性和激活药物靶点。
Sci Rep. 2018 Jan 9;8(1):156. doi: 10.1038/s41598-017-18315-9.

引用本文的文献

1
CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury.CMD-OPT模型能够发现一种强效且具有选择性的RIPK2抑制剂,作为治疗急性肝损伤的临床前候选药物。
Acta Pharm Sin B. 2025 Jul;15(7):3708-3724. doi: 10.1016/j.apsb.2025.05.003. Epub 2025 May 13.
2
Drug Search and Design Considering Cell Specificity of Chemically Induced Gene Expression Profiles for Disease-Associated Tissues.基于化学诱导基因表达谱的细胞特异性对疾病相关组织进行药物搜索与设计
Mol Inform. 2025 Jun;44(5-6):e2444. doi: 10.1002/minf.2444.
3
Capsule neural network and its applications in drug discovery.
胶囊神经网络及其在药物发现中的应用。
iScience. 2025 Mar 14;28(4):112217. doi: 10.1016/j.isci.2025.112217. eCollection 2025 Apr 18.
4
Uncertainty quantification with graph neural networks for efficient molecular design.基于图神经网络的不确定性量化用于高效分子设计。
Nat Commun. 2025 Apr 5;16(1):3262. doi: 10.1038/s41467-025-58503-0.
5
Predicting blood-brain barrier permeability of molecules with a large language model and machine learning.利用大语言模型和机器学习预测分子的血脑屏障通透性。
Sci Rep. 2024 Jul 9;14(1):15844. doi: 10.1038/s41598-024-66897-y.